Alto Neuroscience
(NYSE) ANRO
Alto Neuroscience Financials at a Glance
Market Cap
$901.91MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$74.31M
EPS (TTM)
-$2.48
P/E Ratio
-10.36
Dividend
$0.00
Beta (Volatility)
1.68 (High)
Dividend
$0.00
Beta (Volatility)
1.68 (High)
Price
$25.95
Volume
884,717
Open
$25.76
Price
$25.95
Volume
884,717
Open
$25.76
Previous Close
$26.09
Daily Range
$24.58 - $27.20
52-Week Range
$2.50 - $28.44
Estimated Earnings Date
Aug 12, 2026
Dividend
$0.00
Beta (Volatility)
1.68 (High)
Price
$25.95
Volume
884,717
Open
$25.76
Previous Close
$26.09
Daily Range
$24.58 - $27.20
52-Week Range
$2.50 - $28.44
Estimated Earnings Date
Aug 12, 2026
ANRO News
ANRO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Alto Neuroscience
Industry
Pharmaceuticals
Sector
Health CareEmployees
68
CEO
Amit Etkin, MD, PhD
Website
www.altoneuroscience.comHeadquarters
Mountain View, CA 94022, US
ANRO Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-47.22%
Return on Capital
-42.66%
Return on Assets
-26.90%
Earnings Yield
-9.65%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$901.91MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
35.09M
Volume
884.72K
Avg. Volume
420.00K
Financials (TTM)
Gross Profit
-$284.00K
Operating Income
$54.90M
EBITDA
-$71.29M
Operating Cash Flow
-$62.30M
Capital Expenditure
-$556.00K
Free Cash Flow
-$62.86M
Cash & ST Invst.
$263.76M
Total Debt
$5.69M
Alto Neuroscience Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$184.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$901.91MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$11.87M
N/A
Employees
76
N/A
Net Income
-$26.24M
-73.0%
EBITDA
-$25.51M
-77.1%
Quarterly Fundamentals
Total Cash
$263.76M
+64.1%
Total Debt
$5.69M
-78.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$3.56M
-86.1%
Short Term Debt
$2.14M
+143.8%
Return on Assets
-26.90%
N/A
Return on Invested Capital
20.86%
N/A
Free Cash Flow
-$27.65M
-66.7%
Operating Cash Flow
-$27.09M
-63.6%